Likewise, the serum concentrations of Tenascin-C and MMP7 are increased in individuals with CRC and have been proposed as biomarkers for primary and metastatic CRC, respectively (Pryczynicz et al., 2013; Takeda et al., 2007). This evidence concerns the gene TNC and colorectal carcinoma.